Optimization of <i>Streptococcus agalactiae</i> Biofilm Culture in a Continuous Flow System for Photoinactivation Studies

<i>Streptococcus agalactiae</i> is a relevant cause of neonatal mortality. It can be transferred to infants via the vaginal tract and cause meningitis, pneumonia, arthritis, or sepsis, among other diseases. The cause of therapy ineffectiveness and infection recurrence is the growth of ba...

Full description

Bibliographic Details
Main Authors: Michal K. Pieranski, Michal Rychlowski, Mariusz Grinholc
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/10/9/1212
_version_ 1797517609973841920
author Michal K. Pieranski
Michal Rychlowski
Mariusz Grinholc
author_facet Michal K. Pieranski
Michal Rychlowski
Mariusz Grinholc
author_sort Michal K. Pieranski
collection DOAJ
description <i>Streptococcus agalactiae</i> is a relevant cause of neonatal mortality. It can be transferred to infants via the vaginal tract and cause meningitis, pneumonia, arthritis, or sepsis, among other diseases. The cause of therapy ineffectiveness and infection recurrence is the growth of bacteria as biofilms. To date, several research teams have attempted to find a suitable medium for the cultivation of <i>S. agalactiae</i> biofilms. Among others, simulated vaginal fluid has been used; however, biofilm production in this medium has been found to be lower than that in tryptic soy broth. We have previously shown that <i>S. agalactiae</i> can be successfully eradicated by photoinactivation in planktonic culture, but there have been no studies on biofilms. The aim of this study was to optimize <i>S. agalactiae</i> biofilm culture conditions to be used in photoinactivation studies. We compared biofilm production by four strains representing the most common serotypes in four different broth media with crystal violet staining. Then, we evaluated stationary biofilm culture in microtiter plates and biofilm growth in a CDC Biofilm Reactor<sup>®</sup> (BioSurface Technologies, Bozeman, MT, USA) under continuous flow conditions. Subsequently, we applied Rose Bengal-mediated photoinactivation to both biofilm models. We have shown that photoinactivation is efficient in biofilm eradication and is not cyto/phototoxic to human keratinocytes. We found conditions allowing for stable and repetitive <i>S. agalactiae</i> biofilm growth in continuous flow conditions, which can be successfully utilized in photoinactivation assays and potentially in all other antibacterial studies.
first_indexed 2024-03-10T07:18:56Z
format Article
id doaj.art-0a0cc3325d23499591bfb099211b7242
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-10T07:18:56Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-0a0cc3325d23499591bfb099211b72422023-11-22T14:43:26ZengMDPI AGPathogens2076-08172021-09-01109121210.3390/pathogens10091212Optimization of <i>Streptococcus agalactiae</i> Biofilm Culture in a Continuous Flow System for Photoinactivation StudiesMichal K. Pieranski0Michal Rychlowski1Mariusz Grinholc2Laboratory of Photobiology and Molecular Diagnostics, Intercollegiate Faculty of Biotechnology University of Gdansk and Medical University of Gdansk, 80-307 Gdansk, PolandLaboratory of Virus Molecular Biology, Intercollegiate Faculty of Biotechnology University of Gdansk and Medical University of Gdansk, 80-307 Gdansk, PolandLaboratory of Photobiology and Molecular Diagnostics, Intercollegiate Faculty of Biotechnology University of Gdansk and Medical University of Gdansk, 80-307 Gdansk, Poland<i>Streptococcus agalactiae</i> is a relevant cause of neonatal mortality. It can be transferred to infants via the vaginal tract and cause meningitis, pneumonia, arthritis, or sepsis, among other diseases. The cause of therapy ineffectiveness and infection recurrence is the growth of bacteria as biofilms. To date, several research teams have attempted to find a suitable medium for the cultivation of <i>S. agalactiae</i> biofilms. Among others, simulated vaginal fluid has been used; however, biofilm production in this medium has been found to be lower than that in tryptic soy broth. We have previously shown that <i>S. agalactiae</i> can be successfully eradicated by photoinactivation in planktonic culture, but there have been no studies on biofilms. The aim of this study was to optimize <i>S. agalactiae</i> biofilm culture conditions to be used in photoinactivation studies. We compared biofilm production by four strains representing the most common serotypes in four different broth media with crystal violet staining. Then, we evaluated stationary biofilm culture in microtiter plates and biofilm growth in a CDC Biofilm Reactor<sup>®</sup> (BioSurface Technologies, Bozeman, MT, USA) under continuous flow conditions. Subsequently, we applied Rose Bengal-mediated photoinactivation to both biofilm models. We have shown that photoinactivation is efficient in biofilm eradication and is not cyto/phototoxic to human keratinocytes. We found conditions allowing for stable and repetitive <i>S. agalactiae</i> biofilm growth in continuous flow conditions, which can be successfully utilized in photoinactivation assays and potentially in all other antibacterial studies.https://www.mdpi.com/2076-0817/10/9/1212<i>S. agalactiae</i>Group B <i>Streptococcus</i> (GBS)biofilmcontinuous flowCenter for Disease Control and Prevention (CDC) Biofilm Reactorphotoinactivation
spellingShingle Michal K. Pieranski
Michal Rychlowski
Mariusz Grinholc
Optimization of <i>Streptococcus agalactiae</i> Biofilm Culture in a Continuous Flow System for Photoinactivation Studies
Pathogens
<i>S. agalactiae</i>
Group B <i>Streptococcus</i> (GBS)
biofilm
continuous flow
Center for Disease Control and Prevention (CDC) Biofilm Reactor
photoinactivation
title Optimization of <i>Streptococcus agalactiae</i> Biofilm Culture in a Continuous Flow System for Photoinactivation Studies
title_full Optimization of <i>Streptococcus agalactiae</i> Biofilm Culture in a Continuous Flow System for Photoinactivation Studies
title_fullStr Optimization of <i>Streptococcus agalactiae</i> Biofilm Culture in a Continuous Flow System for Photoinactivation Studies
title_full_unstemmed Optimization of <i>Streptococcus agalactiae</i> Biofilm Culture in a Continuous Flow System for Photoinactivation Studies
title_short Optimization of <i>Streptococcus agalactiae</i> Biofilm Culture in a Continuous Flow System for Photoinactivation Studies
title_sort optimization of i streptococcus agalactiae i biofilm culture in a continuous flow system for photoinactivation studies
topic <i>S. agalactiae</i>
Group B <i>Streptococcus</i> (GBS)
biofilm
continuous flow
Center for Disease Control and Prevention (CDC) Biofilm Reactor
photoinactivation
url https://www.mdpi.com/2076-0817/10/9/1212
work_keys_str_mv AT michalkpieranski optimizationofistreptococcusagalactiaeibiofilmcultureinacontinuousflowsystemforphotoinactivationstudies
AT michalrychlowski optimizationofistreptococcusagalactiaeibiofilmcultureinacontinuousflowsystemforphotoinactivationstudies
AT mariuszgrinholc optimizationofistreptococcusagalactiaeibiofilmcultureinacontinuousflowsystemforphotoinactivationstudies